Skip to Main Content

Paper Details

Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy.
Leuk Res
23
2017
Author NameAffiliation
Zhaolei ZhangUniversity of Toronto
  • 1 - 1

Datasets

Release 1.2